This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
MikiY, SwensenJ, Shattuck-EidensD, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science1994; 266: 66–71.
WoosterR, BignellG, LancasterJ, et al. Identification of the breast cancer susceptibility gene BRCA2.Nature1995; 378: 789–792.
LynchHT, AlbanoWA, DanesBS, et al. Genetic predisposition to breast cancer.Cancer1984; 53: 612–622.
StruewingJP, HartgeP, WacholderS, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.New Engl J Med1997; 336: 1401–1408.
ClausEB, SchildkrautJM, ThompsonWD, RischNJ. The genetic attributable risk of breast and ovarian cancer.Cancer1996; 77: 2318–2324.
JohannssonOT, IdvallI, AndersonC, et al. Tumour biological features of BRCA1-induced breast and ovarian cancer.Eur J Cancer1997; 33: 362–371.
KaasR, KrogerR, HendriksJH, et al. The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers.Eur Radiol2004; 14: 1647–1653.
HartmannLC, SchaidDJ, WoodsJE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.New Engl J Med1999; 340: 77–84.
EvansD, LallooF, ShentonA, BoggisC, HowellA. Uptake of screening and prevention in women at very high risk of breast cancer.Lancet2001; 358: 889–890.
VasenHF, HaitesNE, EvansDG, et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.Eur J Cancer1998; 34: 1922–1926.
NystromL, AnderssonI, BjurstamN, FrisellJ, NordenskjoldB, RutqvistLE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.Lancet2002; 359: 909–919.
StomperPC, D'SouzaDJ, DiNittoPA, ArredondoMA. Analysis of parenchymal density on mammograms in 1353 women 25–79 years old.Am J Roentgenol1996; 167: 1261–1265.
LehmanCD, WhiteE, PeacockS, DruckerMJ, UrbanN. Effect of age and breast density on screening mammograms with false-positive findings.Am J Roentgenol1999; 173: 1651–1655.
ZonderlandHM, CoerkampEG, HermansJ, van de VijverMJ, van VoorthuisenAE. Diagnosis of breast cancer: contribution of US as an adjunct to mammography.Radiology1999; 213: 413–422.
Shaw de ParedesE, MarstellerLP, EdenBV. Breast cancers in women 35 years of age and younger: mammographic findings.Radiology1990; 177: 117–119.
MorrowM. Identification and management of the woman at increased risk for breast cancer development.Breast Cancer Res Treat1994; 31: 53–60.
PeerPG, VerbeekAL, StraatmanH, HendriksJH, HollandR. Age-specific sensitivities of mammographic screening for breast cancer.Breast Cancer Res Treat1996; 38: 153–160.
Tilanus-LinthorstMM, ObdeijnIM, BartelsKC, de KoningHJ, OudkerkM. First experiences in screening women at high risk for breast cancer with MR imaging.Breast Cancer Res Treat2000; 63: 53–60.
KuhlCK, SchmutzlerRK, LeutnerCC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.Radiology2000; 215: 267–279.
Tilanus-LinthorstM, VerhoogL, ObdeijnIM, et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.Int J Cancer2002; 102: 91–95.
FeigSA. Assessment of radiation risk from screening mammography.Cancer1996; 77: 818–822.
OrelSG, MendoncaMH, ReynoldsC, SchnallMD, SolinLJ, SullivanDC. MR imaging of ductal carcinoma in situ.Radiology1997; 202: 413–420.
ViehwegP, PaproschI, StrassinopoulouM, Heywang-KobrunnerSH. Contrast-enhanced magnetic resonance imaging of the breast: interpretation guidelines.Top Magn Reson Imag1998; 9: 17–43.
WarnerE, PlewesDB, HillKA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.J Am Med Assoc2004; 292: 1317–1325.
HeywangSH, HahnD, SchmidtH, et al. MR imaging of the breast using gadolinium-DTPA.J Comput Assist Tomogr1986; 10: 199–204.
BraschRC, WeinmannHJ, WesbeyGE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex.Am J Roentgenol1984; 142: 625–630.
StrichG, HaganPL, GerberKH, SlutskyRA. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.Radiology1985; 154: 723–726.
ObdeijnIM, KuijpersTJ, van DijkP, WiggersT, OudkerkM. MR lesion detection in a breast cancer population.J Magn Reson Imag1996; 6: 849–854.
BoneB, PentekZ, PerbeckL, VeressB. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.Acta Radiol1997; 38: 489–496.
Heywang-KobrunnerSH, ViehwegP, HeinigA, KuchlerC. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions.Eur J Radiol1997; 24: 94–108.
Tilanus-LinthorstMM, ObdeijnAI, BontenbalM, OudkerkM. MRI in patients with axillary metastases of occult breast carcinoma.Breast Cancer Res Treat1997; 44: 179–182.
MorrisEA, SchwartzLH, DershawDD, et al. MR imaging of the breast in patients with occult primary breast carcinoma.Radiology1997; 205: 437–440.
GillesR, ZafraniB, GuinebretiereJM, et al. Ductal carcinoma in situ: MR imaging–histopathologic correlation.Radiology1995; 196: 415–419.
WesterhofJP, FischerU, MoritzJD, OestmannJW. MR imaging of mammographically detected clustered microcalcifications: is there any value?Radiology1998; 207: 675–681.
BrettJ, AustokerJ, OngG. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment.J Public Health Med1998; 20: 396–403.
GilhuijsKG, DeurlooEE, MullerSH, PeterseJL, Schultze KoolLJ. Breast MR imaging in women at increased lifetime risk of breast cancer: clinical system for computerized assessment of breast lesions initial results.Radiology2002; 225: 907–916.
DeurlooEE, MullerSH, PeterseJL, BesnardAPE, GilhuijsKGA. Clinically and mammographically occult breast lesions at MR imaging: potential impact of computerized assessment on clinical reading.Radiology2005 (in press).
KriegeM, BrekelmansCT, BoetesC, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.New Engl J Med2004; 351: 427–437.
LibermanL. Breast cancer screening with MRI – what are the data for patients at high risk?New Engl J Med2004; 351: 497–500.
RobsonME, OffitK. Breast MRI for women with hereditary cancer risk.J Am Med Assoc2004; 292: 1368–1370.